Human respiratory syncytial virus affects nonadrenergic noncholinergic inhibition in cotton rat airways.
A dysfunction of the nonadrenergic noncholinergic inhibitory (NANCi) system has been invoked as a possible mechanism underlying or contributing to altered airway function. In the present study we assessed whether human respiratory syncytial virus (HRSV) infection affects the airways' neurally mediated contractile and relaxant (NANCi) responses in vitro. NANCi responses were studied on tracheal smooth muscle (TSM) segments obtained from young adult cotton rats, a well-established model for HRSV infection. To assess NANCi responses, TSM segments were removed and placed in tissue baths containing modified Krebs-Henseleit, atropine (1 x 10(-6) M) and propranolol (5 x 10(-6) M). After contraction with neurokinin A (1 x 10(-5) M), electrical field stimulation (EFS) was applied at stimulation frequencies ranging from 5 to 30 Hz. The NANCi responses were measured and expressed as the mean (+/- SE) percent relaxation. To evaluate neurally mediated contractile responses, full frequency response curves (0.5-30 Hz) to EFS were also performed. We found significantly decreased NANCi responses in TSM segments obtained from infected cotton rats (n = 12) compared with control animals (n = 9) (P < 0.002). Furthermore, the contractile responses to EFS were increased in infected animals compared with the control group (P = 0.0001). These findings demonstrate that HRSV infection leads to an enhanced contractile response to EFS and a significant decrease in NANCi response in cotton rat airways in vitro. This disruption of the neural control of airways may lead to the development of altered airway function.
Colasurdo
G N
GN
Division of Pediatric Pulmonary Medicine, National Jewish Center for Immunology and Respiratory Medicine, University of Colorado School of Medicine, Denver 80206, USA.
Hemming
V G
VG
Prince
G A
GA
Loader
J E
JE
Graves
J P
JP
Larsen
G L
GL
D000818:Animals; D001285:Atropine / Q000494:pharmacology*; D002460:Cell Line; D004558:Electric Stimulation; D006801:Humans; D066298:In Vitro Techniques; D009130:Muscle, Smooth / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology*; D015288:Neurokinin A / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology; D018357:Respiratory Syncytial Virus Infections / Q000473:pathology / Q000503:physiopathology*; D018113:Respiratory Syncytial Virus, Human / Q000302:isolation & purification / Q000502:physiology; D016205:Sigmodontinae; D014132:Trachea / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology*; D014779:Virus Replication
D001285:Atropine; D015288:Neurokinin A; D011433:Propranolol